-
2
-
-
69249235445
-
A case for water in the treatment of polycystic kidney disease
-
Torres VE, Bankir L, Grantham JJ. A case for water in the treatment of polycystic kidney disease. Clin J Am Soc Nephrol. 2009;4:1140-1150.
-
(2009)
Clin J Am Soc Nephrol.
, vol.4
, pp. 1140-1150
-
-
Torres, V.E.1
Bankir, L.2
Grantham, J.J.3
-
3
-
-
0035882327
-
Antidiuretic action of vasopressin: Quantitative aspects and interaction between V1a and V2 receptor-mediated effects
-
Bankir L. Antidiuretic action of vasopressin: quantitative aspects and interaction between V1a and V2 receptor-mediated effects. Cardiovasc Res. 2001;51:372-390.
-
(2001)
Cardiovasc Res.
, vol.51
, pp. 372-390
-
-
Bankir, L.1
-
4
-
-
33644521546
-
Molecular biology of hereditary diabetes insipidus
-
Fujiwara TM, Bichet DG. Molecular biology of hereditary diabetes insipidus. J Am Soc Nephrol. 2005;16:2836-2846.
-
(2005)
J Am Soc Nephrol.
, vol.16
, pp. 2836-2846
-
-
Fujiwara, T.M.1
Bichet, D.G.2
-
5
-
-
43049146180
-
Non-peptide argininevasopressin antagonists: The vaptans
-
Decaux G, Soupart A, Vassart G. Non-peptide argininevasopressin antagonists: the vaptans. Lancet. 2008;371: 1624-1632.
-
(2008)
Lancet.
, vol.371
, pp. 1624-1632
-
-
Decaux, G.1
Soupart, A.2
Vassart, G.3
-
6
-
-
84875758393
-
Vasopressin: A novel target for the prevention and retardation of kidney disease?
-
published online ahead of print February 26, 2013
-
Bankir L, Bouby N, Ritz E. Vasopressin: a novel target for the prevention and retardation of kidney disease? [published online ahead of print February 26, 2013] Nat Rev Nephrol. 2013.
-
(2013)
Nat Rev Nephrol.
-
-
Bankir, L.1
Bouby, N.2
Ritz, E.3
-
7
-
-
0020774787
-
Osmoregulation of thirst and vasopressin secretion in human subjects: Effect of various solutes
-
Zerbe RL, Robertson GL. Osmoregulation of thirst and vasopressin secretion in human subjects: effect of various solutes. Am J Physiol. 1983;244:E607-E614.
-
(1983)
Am J Physiol.
, vol.244
-
-
Zerbe, R.L.1
Robertson, G.L.2
-
8
-
-
33846787015
-
Sex difference in urine concentration across differing ages, sodium intake, and level of kidney disease
-
Perucca J, Bouby N, Valeix P, Bankir L. Sex difference in urine concentration across differing ages, sodium intake, and level of kidney disease. Am J Physiol Regul Integr Comp Physiol. 2007; 292:R700-R705.
-
(2007)
Am J Physiol Regul Integr Comp Physiol.
, vol.292
-
-
Perucca, J.1
Bouby, N.2
Valeix, P.3
Bankir, L.4
-
9
-
-
34548843043
-
Ethnic differences in urine concentration: Possible relationship to blood pressure
-
Bankir L, Perucca J, Weinberger MH. Ethnic differences in urine concentration: possible relationship to blood pressure. Clin J Am Soc Nephrol. 2007;2:304-312.
-
(2007)
Clin J Am Soc Nephrol.
, vol.2
, pp. 304-312
-
-
Bankir, L.1
Perucca, J.2
Weinberger, M.H.3
-
10
-
-
84861678616
-
New insights into urea and glucose handling by the kidney, and the urine concentrating mechanism
-
Bankir L, Yang B. New insights into urea and glucose handling by the kidney, and the urine concentrating mechanism. Kidney Int. 2012;81:1179-1198.
-
(2012)
Kidney Int.
, vol.81
, pp. 1179-1198
-
-
Bankir, L.1
Yang, B.2
-
11
-
-
78349276885
-
Vasopressin V2 receptors, ENaC, and sodium reabsorption: A risk factor for hypertension?
-
Bankir L, Bichet DG, Bouby N. Vasopressin V2 receptors, ENaC, and sodium reabsorption: a risk factor for hypertension? Am J Physiol Renal Physiol. 2010;299:F917-F928.
-
(2010)
Am J Physiol Renal Physiol.
, vol.299
-
-
Bankir, L.1
Bichet, D.G.2
Bouby, N.3
-
12
-
-
0030369740
-
Vasopressin increases glomerular filtration rate in conscious rats through its antidiuretic action
-
Bouby N, Ahloulay M, Nsegbe E, Dechaux M, Schmitt F, Bankir L. Vasopressin increases glomerular filtration rate in conscious rats through its antidiuretic action. J Am Soc Nephrol. 1996; 7:842-851.
-
(1996)
J Am Soc Nephrol.
, vol.7
, pp. 842-851
-
-
Bouby, N.1
Ahloulay, M.2
Nsegbe, E.3
Dechaux, M.4
Schmitt, F.5
Bankir, L.6
-
13
-
-
0034925210
-
Level of hydration and renal function in healthy humans
-
Anastasio P, Cirillo M, Spitali L, Frangiosa A, Pollastro RM, De Santo NG. Level of hydration and renal function in healthy humans. Kidney Int. 2001;60:748-756.
-
(2001)
Kidney Int.
, vol.60
, pp. 748-756
-
-
Anastasio, P.1
Cirillo, M.2
Spitali, L.3
Frangiosa, A.4
Pollastro, R.M.5
De Santo, N.G.6
-
14
-
-
0030006672
-
Direct and indirect cost of urea excretion
-
Bankir L, Bouby N, Trinh-Trang-Tan MM, Ahloulay M, Promeneur D. Direct and indirect cost of urea excretion. Kidney Int. 1996;49:1598-1607.
-
(1996)
Kidney Int.
, vol.49
, pp. 1598-1607
-
-
Bankir, L.1
Bouby, N.2
Trinh-Trang-Tan, M.M.3
Ahloulay, M.4
Promeneur, D.5
-
15
-
-
0022387213
-
Nephron adaptation to renal injury or ablation
-
Brenner BM. Nephron adaptation to renal injury or ablation. Am J Physiol. 1985;249:F324-F337.
-
(1985)
Am J Physiol.
, vol.249
-
-
Brenner, B.M.1
-
16
-
-
0041883699
-
Diabetes-induced albuminuria: Role of antidiuretic hormone as revealed by chronic V2 receptor antagonism in rats
-
Bardoux P, Bruneval P, Heudes D, Bouby N, Bankir L. Diabetes-induced albuminuria: role of antidiuretic hormone as revealed by chronic V2 receptor antagonism in rats. Nephrol Dial Transplant. 2003;18:1755-1763.
-
(2003)
Nephrol Dial Transplant.
, vol.18
, pp. 1755-1763
-
-
Bardoux, P.1
Bruneval, P.2
Heudes, D.3
Bouby, N.4
Bankir, L.5
-
17
-
-
0025209989
-
Effect of water intake on the progression of chronic renal failure in the 5/6 nephrectomized rat
-
Bouby N, Bachmann S, Bichet D, Bankir L. Effect of water intake on the progression of chronic renal failure in the 5/6 nephrectomized rat. Am J Physiol. 1990;258:F973-F979.
-
(1990)
Am J Physiol.
, vol.258
-
-
Bouby, N.1
Bachmann, S.2
Bichet, D.3
Bankir, L.4
-
18
-
-
80655131138
-
Urine volume and change in estimated GFR in a community-based cohort study
-
Clark WF, Sontrop JM, Macnab JJ, et al. Urine volume and change in estimated GFR in a community-based cohort study. Clin J Am Soc Nephrol. 2011;6:2634-2641.
-
(2011)
Clin J Am Soc Nephrol.
, vol.6
, pp. 2634-2641
-
-
Clark, W.F.1
Sontrop, J.M.2
MacNab, J.J.3
-
19
-
-
84881624518
-
The TEMPO 3:4 Trial Investigators. Tolvaptan in patients with autosomal dominant polycystic kidney disease
-
Torres VE, Chapman AB, Devuyst O, et al, The TEMPO 3:4 Trial Investigators. Tolvaptan in patients with autosomal dominant polycystic kidney disease. N Engl J Med. 2012.
-
(2012)
N Engl J Med.
-
-
Torres, V.E.1
Chapman, A.B.2
Devuyst, O.3
|